Kanza, plainly stated
About
Kanza is an independent resource on ibogaine, noribogaine, and alcohol use disorder. It exists to help people find early research, safety considerations, regulatory context, and the questions that remain unanswered.
Why this exists
Clear context can be difficult to find.
Information around emerging health topics is often uneven: research, regulation, personal accounts, and commercial claims can appear beside one another without much explanation of their differences. Kanza was created to make room for careful orientation rather than quick conclusions.
Its scope is narrow and deliberate. The main topic guide introduces the area Kanza covers, while this page explains the resource itself: its purpose, working principles, and limits. Kanza does not offer medical or legal advice, and it does not direct readers toward a particular treatment choice.
Independence means stating what is known, what is preliminary, and what cannot be concluded from the available material.
Our editorial approach
Method matters as much as material.
Kanza uses published literature, study registries, official sources, and primary records where possible. Research is read with attention to study design, scope, and uncertainty; readers can independently search registered studies through the U.S. National Library of Medicine’s ClinicalTrials.gov registry.
We distinguish between early signals and settled findings, and we do not treat marketing language as evidence. Where a source makes a factual claim about U.S. regulatory status, Kanza checks it against primary material such as the FDA’s drug information resources.
- IndependenceNo clinic, provider, or treatment center perspective sets the agenda.
- Evidence before hypeClaims are framed in proportion to the quality and limits of the available record.
- Safety awarenessRisks, screening questions, and unresolved issues are not treated as footnotes.
- Plain languageTechnical material is organized for people who need orientation, not persuasion.
- TransparencyThe difference between source material, interpretation, and uncertainty is made visible.
What we cover
A structured route through complicated information.
Kanza organizes material around evidence, safety and screening, trials and access, and practical questions about how information should be assessed. The resource pathways describe that structure and the kinds of questions each area is designed to help readers consider.
We also recognize that people may encounter very different kinds of websites while searching. References to an ibogaine Mexico clinic, Mexico ibogaine treatment, or an ibogaine clinic in Mexico belong to a broader search landscape; Kanza does not endorse or operate any of them.
Likewise, pages describing what an ibogaine treatment is, discussing ibogaine treatment for Parkinson’s, or promoting ibogaine treatment in Texas may use overlapping language while addressing different questions. Kanza’s role is limited to helping readers recognize the need for source-aware, safety-conscious context.
Who this is for
For people looking for a steadier starting point.
Kanza is for people affected by alcohol use disorder, their supporters, and others seeking clear context on ibogaine-related claims and research. It is also for readers who want to understand how an information source reaches its limits before they rely on it.
That includes people comparing descriptions of ibogaine treatment facilities with publicly available records, and people trying to separate a provider’s own description from independent source material. The aim is not to make a decision for anyone; it is to make the process of asking better questions more accessible.
Independent by design
Information is not care.
Kanza is an independent information resource, not a clinic, medical provider, or licensed treatment center. Nothing here is medical or legal advice, and the resource does not replace individual evaluation by appropriately qualified professionals.
For readers who need immediate help with alcohol-related concerns, the SAMHSA National Helpline information describes confidential treatment referral and support options in the United States.